cardiovascular diseases
284 projects
H2020Individual fellowship2017–2020United Kingdom
TEDCIP · Targeting epigenetic demethylases: development of covalent inhibitors and PROTACs (Proteolysis Targeting Chimeras).
H2020Individual fellowship2017–2020France
PIMS · Mechanistic studies of long chain omega-3 fatty acid supplementation and inflammation in metabolic syndrome.
2 partners · 2 countries
H2020Doctoral network2017–2021Netherlands
INTRICARE · International Network for Training on Risks of vascular Intimal Calcification And roads to Regression of cardiovascular diseasE
3 partners · 3 countries
H2020Individual fellowship2017–2019Denmark
ANATOMY-FOUND · Novel Imaging of the heart for new structural and metabolic diagnosis
H2020Individual fellowship2017–2019Spain
CLIP · Comprehensive Lifestyle Intervention Project (CLIP)
2 partners · 2 countries
H2020Individual fellowship2017–2019Italy
Fit-The-Fat · IMMUNOMETABOLISM IN HUMAN OBESITY
H2020Individual fellowship2017–2019France
DISTRICT · DECIPHERING THE ROLE OF TRIB1 IN REGULATORY T CELLS
H2020Individual fellowship2017–2018United Kingdom
MONOCLE · A novel enhancer deletion strategy to determine non-classical monocyte function in atherosclerosis
H2020Individual fellowship2017–2021Spain
INTERPLAY · Interplay between genetic determinants of glycaemia, type 2 diabetes and cardiovascular disease in interaction with dietary and lifestyle factors
2 partners · 2 countries
H2020Individual fellowship2017–2019France
ZEBRA-VALVE · “Quantitative analysis of the molecular and cellular behaviors associated with cardiac valve morphogenesis in pathological and regenerative contexts”
H2020Individual fellowship2016–2019Ireland
LAF-GRAFT · An Investigation into the viability of employing lipoaspirate fluid as a cellular source in the production of small diameter tissue engineered vascular grafts
2 partners · 2 countries
H2020Individual fellowship2016–2019Spain
MERC · Molecular mechanisms regulating cardiovascular remodeling by Adamts1
H2020Individual fellowship2016–2019Italy
AGORAs · AGeing effects on human aORta: from shApe to flowS
2 partners · 2 countries
H2020Individual fellowship2016–2018Sweden
EpiHope · Epigenetic biomarkers for prediction of vascular complications and response to treatment in subjects with diabetes
H2020Individual fellowship2016–2019United Kingdom
HIT-LVAD · Understanding blood pressure and vascular haemodynamics in implanted Left Ventricular Assist Device patients.
2 partners · 2 countries
H2020Individual fellowship2016–2018Germany
EHT-CaMKII · CaMKII over stimulation in engineered heart tissues (EHTs) made from human induced pluripotent stem cells (hiPSCs): a parameter involved in the immaturity of hiPSC EHTs cardiomyocytes?
H2020Individual fellowship2016–2019Netherlands
CAMEOS · Cardiac micro-engineered tissue for high-throughput screening
3 partners · 2 countries
H2020Individual fellowship2016–2018United Kingdom
HeartAtaK · Targeting the Anti-Target: From Structure to Drug in the heart Kv11.1 channel
H2020Individual fellowship2016–2018Ireland
NIR-BIO-FLU · Bio-conjugatable and Bio-responsive Near Infrared Fluorochromes
H2020Individual fellowship2016–2018Denmark
Gut-InflammAge · Age-associated signatures in the composition and pro-inflammatory status of the gut microbiome in humans and mice, and the impact of a periodic fasting intervention to promote healthy aging
H2020Individual fellowship2016–2018Germany
GCG-T3 Dyslipidemia · Validation and Molecular Characterization of Novel Glucagon-Thyroid Hormone Conjugates for the Efficient Management of Dyslipidemia and Fatty Liver Disease
H2020Individual fellowship2016–2018Italy
CKD AKI · Chronic kidney disease and acute kidney injury – evaluation of EU and global epidemiology
H2020Individual fellowship2016–2018Israel
channelopathies · Type 1 reyanodine receptor Structure and regulation by post-translational modifications and small molecules.
H2020Individual fellowship2016–2018Portugal